Evidence map›Paper›PMID 40830471›Full record

ArticleBMC medicine2025

Mental, physical, and respiratory health in people with tuberculosis in Southern Africa: a multi-country cohort analysis.

Nicolas Banholzer, Guy Muula, Fiona Mureithi, Denise Evans, Jacqueline Huwa, Idiovino Rafael, Cordelia Kunzekwenyika, Nelly Jinga, Amina Fernando, Agness Thawani and 9 more

Abstract readMulticenter Study
In one paragraph

Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Nicolas Banholzer *Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Guy Muula *Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Fiona MureithiCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Denise EvansHealth Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Jacqueline Huwa, Lighthouse, Lilongwe, Malawi.
Idiovino RafaelSolidarMed, Chiure, Mozambique.
Cordelia KunzekwenyikaSolidarMed, Masvingo, Zimbabwe.
Nelly JingaHealth Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Amina FernandoSolidarMed, Chiure, Mozambique.
Agness Thawani, Lighthouse, Lilongwe, Malawi.
Remo SchmutzInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Carolyn BoltonCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Gunar GüntherDepartment of Pulmonology, Allergology and Clinical Immunology, Inselspital, University Hospital of Bern, Bern, Switzerland.
Matthias EggerInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Andreas D HaasInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Annika C SweetlandDepartment of Psychiatry, Columbia Vagelos College of Physicians and Surgeons/New York State Psychiatric Institute, New York, NY, USA.
Marie BallifInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Lukas FennerInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland. lukas.fenner@unibe.ch.
IeDEA Southern Africa (IeDEA-SA)

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
Malawi HIV Implementation Research Scientist Training Program (MHIRST)D43TW010060 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MINA CHRISTINE HOSSEINIPOUR, Victor Mwapasa · 2015 to 2026
$3.8M
FIC NIH HHS D43 TW010060National Institute of Allergy And Infectious Diseases U01AI069924NIAID NIH HHS U01 AI069924
6 · The paper itself

Abstract

backgroundTuberculosis (TB) affects people's quality of life (QoL). We prospectively monitored physical and mental health-related QoL over time in people with TB in the Southern African region with a high HIV and TB burden.

methodsAdults aged ≥ 15 years with pulmonary TB were enrolled in five cohorts in Malawi, Mozambique, South Africa, Zambia, and Zimbabwe from October 2022 to September 2024. We assessed six QoL outcomes using validated instruments at the start (baseline), end of treatment, and 6 months post-treatment: symptoms of depression (PHQ-9), mental and physical health (SF-12 mental, SF12-MC, SF-12 physical component, SF12-PC), physical fitness (6-Minute Walk Test, 6MWT; 1-min Sit-To-Stand Test, STST), and respiratory health (Saint-George-Respiratory-Questionnaire, SGRQ). Missing QoL scores were imputed with multivariate imputation by chained equations. We compared the proportion of participants with impaired QoL, defining impairment based on outcome-specific cut-off values. We also estimated changes in QoL scores and examined their associations with baseline characteristics using Bayesian multivariable regression models.

resultsWe included 1438 participants with a median follow-up of 344 days (interquartile range [IQR] 183-373). The median age was 39 years (IQR 30-50); 67% were male, and 39% living with HIV. At baseline, 49% had symptoms of depression, 73% had impaired mental health and 92% impaired physical health-related QoL, 68-74% had reduced physical fitness (68%: 6MWT, 74%: STST), and 78% impaired respiratory health. All QoL outcomes improved by the end of treatment, notably depressive symptoms (48% to 5%), mental health-related QoL (73% to 28%), and respiratory health (78% to 11%). Most QoL impairments continued to decrease post-treatment, especially physical and respiratory health; depressive symptoms remained below 5%. Across QoL domains and study visits, better outcomes were associated with age < 30 (83% probability), and worse outcomes with female gender (86%) and a prior TB history (89%). Living with HIV and alcohol drinking were associated with worse QoL only at baseline (88% and 87%).

conclusionsTB negatively impacts QoL across physical, mental, and social domains, including post-treatment. The study highlights the need for integrated mental and physical healthcare and rehabilitation during TB treatment and beyond, especially for high-risk populations, to address the long-term impact of TB on QoL.

Indexed as

Mental HealthQuality of LifeTuberculosis, PulmonaryAdolescentAdultAfrica, SouthernCohort StudiesDepressionFemaleHIV InfectionsHumansMaleMiddle AgedPhysical FitnessProspective StudiesYoung AdultAfricaDepressionGenderHIVLow- and middle-income countriesMental healthPhysical fitnessPost-TB complicationsQuality of lifeTB

Identifiers

PMID40830471
PMCPMC12366195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.